Pluripotent human stem cell lines: what we can learn about cancer initiation

Area of Science:

• Stem cell biology
• Cancer research
• Molecular oncology

Background:

• The cancer stem cell (CSC) hypothesis explains tumor recurrence but lacks a defined cell of origin.
• Embryonic stem cell (ESC)-like gene signatures are observed in high-grade tumors, suggesting alternative models for cancer initiation.
• Investigating human pluripotent stem cells (hPSCs) can elucidate early tumorigenic events.

Purpose of the Study:

• To review advances in ESC research and their application to understanding cancer initiation.
• To explore how hPSCs can model early tumorigenic events, including miRNA, epigenetic, proto-oncogene, and tumor suppressor networks.
• To identify novel cell-specific therapeutic targets for cancer by comparing transformed hPSCs with normal counterparts.

Main Methods:

• Review of recent advances in the ESC and hPSC fields.
• Comparative analysis of gene expression and molecular networks in transformed versus normal hPSCs.
• Identification of potential miRNA, epigenetic, proto-oncogene, and tumor suppressor targets.

Main Results:

• hPSCs provide a unique model to study cancer initiation, offering advantages over primary tumor analysis.
• Potential molecular targets (miRNA, epigenetic regulators, oncogenes, tumor suppressors) involved in hierarchical transformation have been identified.
• This approach allows for prospective investigation of tumorigenesis, unlike retrospective studies of CSCs in tumors.

Conclusions:

• hPSCs serve as a powerful model for dissecting early cancer development and identifying therapeutic vulnerabilities.
• Understanding the molecular pathways in transformed hPSCs can lead to the development of novel, cell-specific cancer therapies.
• This research paradigm shifts focus towards understanding cancer initiation through stem cell biology.